Case Study

Oncosec

Gene Therapy/Device Combination Product - Electroporation and Biologics Delivery for Solid Tumor Oncology.

The Challenge

The Challenge

Founded in 2011, OncoSec Medical, Inc. is pioneering gene therapy technology to stimulate the body’s immune system to attack cancer. OncoSec required an innovative Electroporation and Genetic Payload Delivery device capable of accessing cancerous tumors that are beyond the reach of their skin-based technology.

The Solution

The Solution

REV·1 developed multiple design solutions capable of accessing tumors deep in the body, stabilize them and deliver OncoSec’s proprietary Genetic Payload within the tumor through electroporation.

The Result

REV·1 delivered a simple, hand-held device that can be introduced in a minimally invasive, outpatient setting to access tumors deep in the body. Currently in pre-clinical trials, this combination product will radically change the treatment of deep-in-the-body, life-threatening tumors.

Start Developing Your Medical Device Today!

Learn how REV·1 Engineering delivers medical devices 2X Faster than traditional, in- house design and development processes. From concept to commercialization, REV·1 delivers turn-key solutions for today’s most complex medical technologies.